Press release
Genomic Biomarkers Market Poised for Strong Expansion as Precision Medicine Accelerates Worldwide
The global genomic biomarkers market is set for robust growth as precision medicine reshapes diagnostics and therapeutic decision-making across healthcare and life sciences. According to the latest industry analysis, the market is projected to expand from USD 29.00 billion in 2025 to USD 50.31 billion by 2030, registering a compound annual growth rate (CAGR) of 11.6% during the forecast period.
This growth underscores a fundamental shift in how diseases are detected, monitored, and treated, with genomic biomarkers increasingly guiding clinical decisions, drug development strategies, and personalized treatment pathways.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48860286 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48860286&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Market Overview and Scope
The report, "Genomic Biomarkers Market by Product & Service (Consumable, Software), Type (Safety, Efficacy), Technology (NGS, PCR), Disease (Cancer, Infectious) - Forecast to 2030," provides a comprehensive evaluation of market dynamics. It features 708 market data tables and 56 figures across 506 pages, offering deep insights into technology adoption, disease applications, and regional trends.
The genomic biomarkers market is gaining momentum due to the growing use of genomic testing in oncology, rare diseases, and inherited disorders, coupled with rapid advancements in polymerase chain reaction (PCR) and next-generation sequencing (NGS) technologies. These innovations are enabling faster, more accurate, and more scalable biomarker discovery and validation.
Technology Trends: Why NGS Leads the Market
By technology, next-generation sequencing (NGS) accounted for the largest share of the genomic biomarkers market in 2024. What makes NGS critical now is its ability to analyze hundreds of genes and complex molecular signatures in a single run. Hospitals, cancer centers, and pharmaceutical companies increasingly rely on NGS for comprehensive tumor profiling, minimal residual disease detection, and the identification of prognostic and predictive biomarkers.
As precision oncology and multi-gene panel testing become standard practice, NGS continues to outperform traditional methods in terms of depth, efficiency, and clinical relevance.
End-User Insights: Pharma and Biotech Drive Demand
By end users, pharmaceutical and biotechnology companies emerged as the fastest-growing segment in 2024. These organizations depend on genomic biomarkers throughout the drug development lifecycle-from target identification and patient stratification to treatment response monitoring and companion diagnostics development.
The consistent and high-volume demand generated by biomarker-driven clinical trials highlights how genomic insights are becoming integral to reducing drug development risk, improving trial outcomes, and accelerating regulatory approvals.
Regional Outlook: North America Maintains Market Leadership
Regionally, North America accounted for the largest share of the genomic biomarkers market in 2024. This dominance is driven by a strong ecosystem of academic medical centers, cancer institutes, and commercial laboratories that have rapidly adopted NGS-based testing, liquid biopsies, and companion diagnostics.
Favorable reimbursement frameworks, major government initiatives such as the Cancer Moonshot, and sustained investment from pharmaceutical and biotechnology companies in biomarker-led clinical research continue to reinforce North America's leadership in genomic biomarker revenues.
Request For Sample Pages :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=48860286 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=48860286&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Competitive Landscape
The genomic biomarkers market is characterized by the presence of established global players and innovation-driven companies. Key participants include Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Illumina, Inc. (US), QIAGEN (Germany/Netherlands), Bio-Rad Laboratories, Inc. (US), Agilent Technologies, Inc. (US), Eurofins Scientific (Luxembourg), and Quanterix (US). These organizations are actively investing in technology advancements, assay development, and strategic collaborations to strengthen their market positions.
Why This Market Matters Now
As healthcare systems worldwide move toward personalized, data-driven medicine, genomic biomarkers are becoming indispensable for improving diagnostic accuracy, optimizing therapies, and enhancing patient outcomes. For C-suite executives and strategic decision-makers, this market signals sustained opportunities across diagnostics, drug development, software platforms, and laboratory services.
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=genomic-biomarkers-market-poised-for-strong-expansion-as-precision-medicine-accelerates-worldwide]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/genomic-biomarkers-market-48860286.html
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genomic Biomarkers Market Poised for Strong Expansion as Precision Medicine Accelerates Worldwide here
News-ID: 4379267 • Views: …
More Releases from ABNewswire
Visualping Expands API Access for All Users Across Every Plan
Visualping, the world's leading website change detection platform used by teams at 85% of Fortune 500 companies, has announced that its API is now available to all subscribers, not just Business plan users.
VANCOUVER, B.C. - April 16, 2026 - Visualping, the world's leading website change detection platform used by teams at 85% of Fortune 500 companies, has expanded API acess to all users, including free and Personal plan users. Now,…
Holding the System by Robert F. Hill Argues that School Improvement Fails When S …
A persistent challenge in public education reform is the inability of systems to sustain direction long enough for effort to produce measurable and lasting outcomes. Holding the System [https://a.co/d/0hGo1bsf], released by Robert F. Hill, addresses this challenge by repositioning school improvement as a question of structural stability rather than initiative intensity.
The book argues that much of contemporary education reform operates under a misalignment between urgency and capacity. Districts are frequently…
Holding the System Challenges Conventional School Reform Narratives with a Struc …
Public education continues to be shaped by reform cycles that emphasize urgency, visible intervention, and rapid improvement metrics. A new work by Robert F. Hill, Holding the System [https://a.co/d/068SzNsa], offers a direct counter-position: durable improvement in public schools is not the result of acceleration, but of structural coherence maintained over time under constraint.
The book presents a systems-level examination of public education leadership as it is experienced in practice-particularly within high-poverty,…
Best place to buy lab grown diamonds: Whiteflash Precision Lab Sets the Standard …
Whiteflash offers high-quality lab grown diamonds through its Precision Lab line, featuring in-stock stones rigorously evaluated for cut precision, transparency, and light performance. With advanced imaging, top-tier HPHT material, and full certification, Whiteflash ensures transparency, consistency, and confidence for buyers seeking exceptional lab grown diamonds.
Choosing the best place to buy lab grown diamonds requires navigating a market flooded with inconsistent quality and highly variable pricing. Whiteflash addresses this uncertainty with…
More Releases for NGS
Next Generation Sequencing (NGS) : - Key Industry Dynamics
The Next Generation Sequencing (NGS) market size is projected to reach US$ 34.75 billion by 2031 from US$ 10.00 billion in 2023. The market is expected to register a CAGR of 16.8% during 2023-2031. Increased throughput and reduced costs is likely to remain key trends in the market.
Next-generation sequencing (NGS) carries a shift in genomics research, offering unmatched capabilities for analyzing DNA and RNA molecules in a high-throughput and cost-effective…
Next-Generation Sequencing (NGS) Services Next-Generation Sequencing (NGS) Servi …
Global Next-Generation Sequencing (NGS) Services Market Report encompasses market data, such as trends, consumer behavior, and competitive analysis in a way that allows businesses to identify opportunities in the market. The objective of the market research is understood very clearly by DBMR team before the creation of report commences. Intense research takes place to accurately analyze market dynamics and consumer behaviour included in the report.
Global Next-Generation Sequencing (NGS) Services Market,…
Complete PDF Guide to NGS Sample Preparation
The NGS sample preparations determine components in the samples, such as blood, urine, and others, in animals.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 @ https://www.theinsightpartners.com/sample/TIPRE00006573?utm_source=OpenPR&utm_medium=10379
The type of analyzers includes urine analyzers, blood gas & electrolyte analyzers, glucometers, and others used by medical labs, hospitals, and people at home.
Top Companies Analysis -
Agilent Technologies, Inc.
Becton, Dickinson and Company
Beckman Coulter
F. Hoffmann-La Roche AG
Illumina, Inc.
…
NGS Sample Preparation Market - Preparing for Precision: NGS Sample Preparation …
Newark, New Castle, USA: The "NGS Sample Preparation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
NGS Sample Preparation Market: https://www.growthplusreports.com/report/ngs-sample-preparation-market/8504
This latest report researches the industry structure,…
NGS Library Preparation Market - Sequencing Solutions, Redefined: Innovations in …
Newark, New Castle, USA - new report, titled NGS Library Preparation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the NGS Library Preparation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global NGS Library Preparation market. The report offers an overview of…
Next Generation Sequencing (NGS) Data Analysis Market Research Report 2020Next G …
The Next Generation Sequencing (NGS) Data Analysis Market report helps identify the biggest opportunities in Next Generation Sequencing (NGS) Data Analysis industry space and offers accurate latent demand forecasting that empowers quantitative decision making among Next Generation Sequencing (NGS) Data Analysis market players and new entrants. Investors will gain a clear insight on the dominant players in Next Generation Sequencing (NGS) Data Analysis industry and their future forecasts. Furthermore, readers…
